Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessment

Background and Aim Liver stiffness (LS), measured by transient elastography, has been validated as a non‐invasive surrogate for liver fibrosis. Methods We investigated the long‐term predictive ability of LS for hepatocellular carcinoma (HCC) development and overall survival in 1146 patients with chr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of gastroenterology and hepatology 2019-05, Vol.34 (5), p.921-928
Hauptverfasser:	Nakagomi, Ryo, Tateishi, Ryosuke, Masuzaki, Ryota, Soroida, Yoko, Iwai, Tomomi, Kondo, Mayuko, Fujiwara, Naoto, Sato, Masaya, Minami, Tatsuya, Uchino, Koji, Enooku, Kenichiro, Nakagawa, Hayato, Asaoka, Yoshinari, Kondo, Yuji, Tanaka, Yasuo, Otsuka, Motoyuki, Kato, Naoya, Moriya, Kyoji, Ikeda, Hitoshi, Koike, Kazuhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents Fibrosis HCV treatment Hepatitis Hepatitis C hepatitis C, clinical Hepatocellular carcinoma hepatocellular carcinoma, clinical Interferon Liver liver stiffness measurement Risk assessment Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!